DK Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,881	1,959	2,403	3,424	1,381	6,553
Short-Term Investments	700	700	2,150	450	3,150	1,670
Trading Asset Securities	2,602	4,594	-	-	-	-
Cash & Short-Term Investments	8,182	7,254	4,553	3,874	4,531	8,223
Cash Growth	-54.77%	59.31%	17.54%	-14.50%	-44.90%	-61.82%
Accounts Receivable	97,057	90,658	63,908	57,057	47,299	45,889
Other Receivables	1,649	1,596	1,414	1,163	1,122	2,101
Receivables	98,722	92,270	65,416	58,354	48,588	48,214
Inventory	33,516	35,230	42,258	39,647	29,346	19,980
Prepaid Expenses	214.21	88.85	234.55	55.05	59.63	45.75
Other Current Assets	3,754	3,719	3,196	990.08	1,330	2,941
Total Current Assets	144,389	138,560	115,658	102,920	83,854	79,403
Property, Plant & Equipment	68,897	68,254	64,700	64,749	65,106	54,218
Long-Term Investments	2,056	2,055	2,810	2,085	5,255	5,200
Other Intangible Assets	5,067	5,208	5,772	5,935	5,964	5,774
Long-Term Accounts Receivable	0	0	0	0	-0	-0
Long-Term Deferred Tax Assets	2,088	1,873	1,491	1,702	1,695	1,841
Other Long-Term Assets	1,337	1,676	1,227	1,737	2,560	1,459
Total Assets	223,833	217,627	191,658	179,129	164,434	147,894
Accounts Payable	35,930	32,912	28,212	24,259	18,270	14,808
Accrued Expenses	572.37	407.51	429.19	503.94	392.33	352.2
Short-Term Debt	14,200	14,300	22,000	22,600	16,100	13,000
Current Portion of Long-Term Debt	18,717	18,717	396.93	5,729	-	-
Current Portion of Leases	847.88	542.23	323.64	527.75	467.88	208.07
Current Income Taxes Payable	1,720	2,036	2,034	333.08	671.62	-
Other Current Liabilities	12,527	11,758	9,486	9,411	12,903	26,086
Total Current Liabilities	84,514	80,672	62,881	63,363	48,805	54,453
Long-Term Debt	3,588	3,687	22,404	18,750	25,000	10,000
Long-Term Leases	1,922	1,737	105.11	38.05	236.53	204.61
Other Long-Term Liabilities	172.68	164.88	1,043	230.67	238.65	435.51
Total Liabilities	90,196	86,261	86,433	82,382	74,280	65,094
Common Stock	15,992	15,992	6,966	5,629	5,629	5,629
Additional Paid-In Capital	73,505	73,505	64,808	31,809	31,809	31,809
Retained Earnings	45,181	42,875	34,217	31,972	27,805	23,566
Comprehensive Income & Other	-1,041	-1,006	-766.15	-706.36	-114.63	-536.01
Total Common Equity	133,637	131,366	105,224	68,704	65,129	60,469
Shareholders' Equity	133,637	131,366	105,224	96,747	90,154	82,800
Total Liabilities & Equity	223,833	217,627	191,658	179,129	164,434	147,894
Total Debt	39,274	38,983	45,230	47,645	41,804	23,413
Net Cash (Debt)	-31,092	-31,730	-40,676	-43,771	-37,274	-15,190
Net Cash Per Share	-970.75	-1006.61	-1449.67	-3907.82	-33296.60	-13570.02
Filing Date Shares Outstanding	32.03	31.98	37.77	11.2	1.12	1.12
Total Common Shares Outstanding	32.03	31.98	37.77	11.2	1.12	1.12
Working Capital	59,875	57,888	52,776	39,557	35,049	24,950
Book Value Per Share	4172.89	4107.21	2785.92	6133.81	58180.06	54019.63
Tangible Book Value	128,570	126,157	99,452	62,769	59,165	54,695
Tangible Book Value Per Share	4014.67	3944.37	2633.09	5603.93	52852.12	48861.86
Land	9,849	9,849	9,857	9,857	11,737	11,737
Buildings	35,394	34,766	32,131	31,436	9,520	9,240
Machinery	54,179	54,060	50,824	48,467	27,318	24,767
Construction In Progress	7,426	6,041	2,968	622	40,849	30,800